The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

GNPDA1  -  glucosamine-6-phosphate deaminase 1

Homo sapiens

Synonyms: GNP1, GNPDA, GNPDA 1, GNPI, GPI, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of GNPDA1

  • Recombinant GPI-anchored HLA-A2.1 (HLA-A2.1-GPI/beta 2m) was used as a protein transfer vehicle to deliver a hepatitis B virus antigenic peptide to the surfaces of cytotoxic T cell targets [1].
  • Survival of Helicobacter pylori From complement lysis by binding of GPI-anchored protectin (CD59) [2].
  • A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins [3].
  • Type B antibodies recognize other parts of beta2-GPI and are not associated with thrombosis [4].
  • METHODS: Six human affinity-purified polyclonal anti-beta 2 GPI IgG and 2 IgM monoclonal antibodies (MAb) were obtained from patients with the antiphospholipid syndrome [5].
 

Psychiatry related information on GNPDA1

  • In one, patients with moderately severe Parkinson's disease showed no overall improvement in fine motor skills following 6 months of treatment by the neuroimmunophilin GPI 1485 [6].
  • Symptoms and signs differ in many respects from those generally observed in GPI deficiency, as mental retardation, drug sensitivity and increased susceptibility to infections were present [7].
 

High impact information on GNPDA1

  • Nanoscale organization of multiple GPI-anchored proteins in living cell membranes [8].
  • Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion [9].
  • Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing [10].
  • Autoantibodies to GPI and creatine kinase in RA [11].
  • In addition, discordant expression of GPI-linked molecules in individual cells is not restricted to PMN since DAF+/CD14- monocytes were observed in one PNH patient [12].
 

Chemical compound and disease context of GNPDA1

  • Erythrocytes that do not express GPI-linked proteins, obtained from patients with paroxysmal nocturnal hemoglobinuria (PNH), release between 10% and 50% of the quantity of vesicles as normal cells in response to the Ca2+ ionophore A23187 [13].
  • Glycosphingolipids are not essential for formation of detergent-resistant membrane rafts in melanoma cells. methyl-beta-cyclodextrin does not affect cell surface transport of a GPI-anchored protein [14].
  • Oscillin, an extracellular, Ca2+-binding glycoprotein essential for the gliding motility of cyanobacteria [15].
  • Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma [16].
  • We wanted to examine whether increased levels of antibodies to negatively-charged phospholipids (cardiolipin), to phospholipid-binding plasma proteins beta2-GPI and prothrombin and to oxidised low-density lipoprotein (LDL) were associated with risk of deep venous thrombosis or pulmonary embolism in subjects with no previous thrombosis [17].
 

Biological context of GNPDA1

 

Anatomical context of GNPDA1

 

Associations of GNPDA1 with chemical compounds

  • Glucosamine-6-phosphate deaminase (EC 3.5.99.6) is an allosteric enzyme that catalyzes the reversible conversion of D-glucosamine-6-phosphate into D-fructose-6-phosphate and ammonium [23].
  • Like GNPI, the recombinant GNPI2 has been proved to have the enzymatic activity to catalyze the conversion of GNP to fructose-6-phosphate [20].
  • Since GNPDA is the sole enzyme linking hexosamine systems with glycolytic pathways, we propose that it provides a source of energy in the form of phosphosugar derived from the catabolism of hexosamines found in glycoproteins, glycolipids, and sialic acid-containing macromolecules [22].
  • GPI-deficient erythrocytes incubated with glucose in the medium showed an accentuation of membrane protein aggregate formation; however, this was almost completely reversed by the addition of adenine and inosine to the incubation medium or by the use of fructose, the intermediate just distal to the "block" in glycolysis, as the sole substrate [24].
  • ATP and reduced glutathione levels in the GPI-deficient erythrocytes incubated with glucose were similar to that found in the low and high reticulocyte controls [24].
 

Other interactions of GNPDA1

 

Analytical, diagnostic and therapeutic context of GNPDA1

  • Sequence analysis of the hamster sperm 33 kDa protein indicated no similarity to any known cell signalling molecule, however, it displayed extensive homology with a bacterial glucosamine-6-phosphate deaminase [18].
  • Northern blot analysis indicated that the tissue distribution of GNPI2 mRNA is different from that of human GNPI or Oscillin mRNA [20].
  • The concentration of GPI-related antigen was as reduced as the GPI enzymatic activity, and the defect was not improved by any treatment (cross-incubation of red cells or treatment of the hemolysate by SH reagents); the residual enzyme had a normal stability to heat, and a normal electrophoretic and electrofocusing pattern [26].
  • Digestion of platelet membrane glycoproteins (GP(s] with chymotrypsin demonstrated that upon removal of GPI, RIPA was absent, CIPA retained and the CoI-PAR was progressive inhibition, with no enhancement [27].
  • The reactivity of monoclonal aCL with various PLs, with DNA, and with beta 2-GPI was examined by enzyme-linked immunosorbent assay (ELISA) [28].

References

  1. Protein transfer of preformed MHC-peptide complexes sensitizes target cells to T cell cytolysis. Huang, J.H., Getty, R.R., Chisari, F.V., Fowler, P., Greenspan, N.S., Tykocinski, M.L. Immunity (1994) [Pubmed]
  2. Survival of Helicobacter pylori From complement lysis by binding of GPI-anchored protectin (CD59). Rautemaa, R., Rautelin, H., Puolakkainen, P., Kokkola, A., Kärkkäinen, P., Meri, S. Gastroenterology (2001) [Pubmed]
  3. A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins. Dunn, D.E., Yu, J., Nagarajan, S., Devetten, M., Weichold, F.F., Medof, M.E., Young, N.S., Liu, J.M. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  4. Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. de Laat, B., Derksen, R.H., van Lummel, M., Pennings, M.T., de Groot, P.G. Blood (2006) [Pubmed]
  5. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Del Papa, N., Guidali, L., Sala, A., Buccellati, C., Khamashta, M.A., Ichikawa, K., Koike, T., Balestrieri, G., Tincani, A., Hughes, G.R., Meroni, P.L. Arthritis Rheum. (1997) [Pubmed]
  6. Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease? Poulter, M.O., Payne, K.B., Steiner, J.P. Neuroscience (2004) [Pubmed]
  7. Haematological studies in a new variant of glucosephosphate isomerase deficiency (GPI Utrecht). Helleman, P.W., Van Biervliet, J.P. Helvetica paediatrica acta. (1976) [Pubmed]
  8. Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Sharma, P., Varma, R., Sarasij, R.C., Ira, n.u.l.l., Gousset, K., Krishnamoorthy, G., Rao, M., Mayor, S. Cell (2004) [Pubmed]
  9. Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion. Davy, A., Gale, N.W., Murray, E.W., Klinghoffer, R.A., Soriano, P., Feuerstein, C., Robbins, S.M. Genes Dev. (1999) [Pubmed]
  10. Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing. Aurrand-Lions, M., Galland, F., Bazin, H., Zakharyev, V.M., Imhof, B.A., Naquet, P. Immunity (1996) [Pubmed]
  11. Autoantibodies to GPI and creatine kinase in RA. Schubert, D., Schmidt, M., Zaiss, D., Jungblut, P.R., Kamradt, T. Nat. Immunol. (2002) [Pubmed]
  12. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins. Edberg, J.C., Salmon, J.E., Whitlow, M., Kimberly, R.P. J. Clin. Invest. (1991) [Pubmed]
  13. Cells lacking glycan phosphatidylinositol-linked proteins have impaired ability to vesiculate. Whitlow, M., Iida, K., Marshall, P., Silber, R., Nussenzweig, V. Blood (1993) [Pubmed]
  14. Glycosphingolipids are not essential for formation of detergent-resistant membrane rafts in melanoma cells. methyl-beta-cyclodextrin does not affect cell surface transport of a GPI-anchored protein. Ostermeyer, A.G., Beckrich, B.T., Ivarson, K.A., Grove, K.E., Brown, D.A. J. Biol. Chem. (1999) [Pubmed]
  15. Oscillin, an extracellular, Ca2+-binding glycoprotein essential for the gliding motility of cyanobacteria. Hoiczyk, E., Baumeister, W. Mol. Microbiol. (1997) [Pubmed]
  16. Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma. Tentori, L., Leonetti, C., Scarsella, M., D'Amati, G., Vergati, M., Portarena, I., Xu, W., Kalish, V., Zupi, G., Zhang, J., Graziani, G. Clin. Cancer Res. (2003) [Pubmed]
  17. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study. Palosuo, T., Virtamo, J., Haukka, J., Taylor, P.R., Aho, K., Puurunen, M., Vaarala, O. Thromb. Haemost. (1997) [Pubmed]
  18. The human glucosamine-6-phosphate deaminase gene: cDNA cloning and expression, genomic organization and chromosomal localization. Shevchenko, V., Hogben, M., Ekong, R., Parrington, J., Lai, F.A. Gene (1998) [Pubmed]
  19. Evolution, structure, and expression of GNPI/Oscillin orthologous genes. Nakamura, Y., Miura, K., Fujino, Y., Iwao, H., Ogita, S., Yamanaka, S. Genomics (2000) [Pubmed]
  20. Cloning and functional characterization of GNPI2, a novel human homolog of glucosamine-6-phosphate isomerase/oscillin. Zhang, J., Zhang, W., Zou, D., Chen, G., Wan, T., Li, N., Cao, X. J. Cell. Biochem. (2003) [Pubmed]
  21. Glucosamine 6-phosphate deaminase in normal human erythrocytes. Weidanz, J.A., Campbell, P., DeLucas, L.J., Jin, J., Moore, D., Rodén, L., Yu, H., Heilmann, E., Vezza, A.C. Br. J. Haematol. (1995) [Pubmed]
  22. Molecularly cloned mammalian glucosamine-6-phosphate deaminase localizes to transporting epithelium and lacks oscillin activity. Wolosker, H., Kline, D., Bian, Y., Blackshaw, S., Cameron, A.M., Fralich, T.J., Schnaar, R.L., Snyder, S.H. FASEB J. (1998) [Pubmed]
  23. Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study. Arreola, R., Valderrama, B., Morante, M.L., Horjales, E. FEBS Lett. (2003) [Pubmed]
  24. Erythrocyte membrane proteins in hereditary glucosephosphate isomerase deficiency. Coetzer, T., Zail, S.S. J. Clin. Invest. (1979) [Pubmed]
  25. Effects of N-acetylglucosamine on carbohydrate fermentation by Streptococcus mutans NCTC 10449 and Streptococcus sobrinus SL-1. Homer, K.A., Patel, R., Beighton, D. Infect. Immun. (1993) [Pubmed]
  26. Causal mechanisms of multiple acquired red cell enzyme defects in a patient with acquired dyserythropoiesis. Kahn, A., Cottreau, D., Boyer, C., Marie, J., Galand, C., Boivin, P. Blood (1976) [Pubmed]
  27. Platelet-collagen interaction: inhibition by ristocetin and enhancement by von Willebrand factor-platelet binding. LaDuca, F.M., Bettigole, R.E., Bell, W.R., Robson, E.B. Blood (1986) [Pubmed]
  28. beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Ichikawa, K., Khamashta, M.A., Koike, T., Matsuura, E., Hughes, G.R. Arthritis Rheum. (1994) [Pubmed]
 
WikiGenes - Universities